Related Experiment Video
Updated: Aug 24, 2026
Megakaryocyte Differentiation and Platelet Formation from Human Cord Blood-derived CD34+ Cells
Published on: December 27, 2017
[A study on micromegakaryocyte in children with idiopathic thrombocytopenic purpura]
Xiao-dong Shi1, Tao Hu, Yan-ling Feng
1Capital Institute of Pediatrics, Beijing 100020, China.
Objective:
Bone marrow megakaryocytes overly proliferate and abnormally develop among patients with idiopathic thrombocytopenic purpura (ITP). Previous studies showed that it resulted from the abnormal immune function of the body. But the changes in megakaryocytes, especially in micromegakaryocytes in this disease are unclear. The present study was designed to explore the growth and development status of megakaryocytes and the significance of changes in micromegakaryocytes in pediatric cases.
Methods:
Routine bone marrow smears assay and enzyme labeling for micromegakaryocytes with CD41 monoclonal antibody (McAb) were performed in 46 children with ITP. The level of platelet-associated immunoglobulin (PA-Ig) was measured with ELISA.
Results:
Among 46 children, 36 had acute ITP (AITP)and 10 chronic ITP (CITP). The number of megakaryocytes increased or was normal in 45 patients, but decreased only in 1 case of CITP. The positive rate of micromegakaryocytes and type I micromegakaryocytes was 98% (45/46) and 35% (16/46), respectively. The positive rate of type I micromegakaryocytes was higher in CITP (50%) cases than that in AITP (31%) cases, but the median of the other three types of micromegakaryocytes in CITP cases (159) was lower than that in the AITP cases (336). There was no relationship between the numbre of all types of megakaryocytes and the level of PA-Ig.
Conclusion:
Majority of patients with ITP showed an increase in micromegakaryocytes, especially in type II, III and IV. The immune disturbance might not be the only reason for ITP. The abnormality of quality of megakaryocytes might be one of the potential causes for thrombocytopenia in some cases of ITP, especially in those of CITP. The appearance and the number of type I micromegakaryocytes might reflect the prognosis of cases of ITP.
Insights
Idiopathic thrombocytopenic purpura (ITP) in children often involves increased micromegakaryocytes, suggesting megakaryocyte quality abnormalities may contribute to low platelets. Type I micromegakaryocytes may indicate prognosis in ITP cases.
Area of Science:
- Hematology
- Immunology
- Pediatric Medicine
Context:
- Idiopathic thrombocytopenic purpura (ITP) is characterized by abnormal megakaryocyte proliferation and development.
- The specific changes in megakaryocytes, particularly micromegakaryocytes, in pediatric ITP remain unclear.
- Previous research suggests immune dysfunction as a cause, but other factors may be involved.
Purpose:
- To investigate the growth and development of megakaryocytes in pediatric ITP.
- To explore the significance of micromegakaryocyte changes in pediatric ITP.
- To assess the relationship between megakaryocyte abnormalities and thrombocytopenia.
Summary:
- Bone marrow smears and CD41 antibody labeling were used in 46 children with ITP.
- A high prevalence of micromegakaryocytes (98%) was observed, with type I micromegakaryocytes noted in 35%.
- Micromegakaryocyte patterns differed between acute and chronic ITP, and no correlation was found with platelet-associated immunoglobulin levels.
Impact:
- Findings suggest that megakaryocyte quality abnormalities, not solely immune disturbances, may contribute to thrombocytopenia in ITP, especially chronic forms.
- The presence and quantity of type I micromegakaryocytes may serve as a prognostic indicator in pediatric ITP.
- This research deepens the understanding of ITP pathogenesis and highlights potential diagnostic markers.
